Snider Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.5M Sell
12,128
-223
-2% -$228K 3.7% 6
2026
Q1
$11.4M Sell
12,351
-333
-3% -$338K 3.43% 6
2025
Q4
$13.6M Sell
12,684
-414
-3% -$396K 3.63% 6
2025
Q3
$9.99M Buy
13,098
+832
+7% +$619K 2.73% 9
2025
Q2
$9.56M Buy
12,266
+450
+4% +$350K 2.76% 7
2025
Q1
$9.76M Sell
11,816
-62
-0.5% -$51.6K 3.17% 7
2024
Q4
$9.17M Buy
11,878
+184
+2% +$152K 2.84% 9
2024
Q3
$10.4M Sell
11,694
-195
-2% -$175K 3.79% 5
2024
Q2
$10.8M Buy
11,889
+14
+0.1% +$11.2K 4.16% 4
2024
Q1
$9.24M Buy
11,875
+674
+6% +$480K 3.85% 4
2023
Q4
$6.53M Sell
11,201
-155
-1% -$90.5K 3.01% 10
2023
Q3
$6.1M Buy
11,356
+810
+8% +$417K 2.95% 12
2023
Q2
$4.95M Buy
10,546
+1,887
+22% +$791K 2.37% 11
2023
Q1
$2.97M Hold
8,659
1.59% 25
2022
Q4
$3.17M Buy
+8,659
New +$3.07M 1.75% 19

Other funds holding LLY

Snider Financial Group's LLY Position: Q2 2026 in Review

Snider Financial Group reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $228K and leaving 12,128 shares worth $14.5M. The position accounts for 3.7% of the portfolio, ranked #6.

Snider Financial Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 852 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Snider Financial Group held 12,128 shares of Eli Lilly worth $14.5M as of Q2 2026.
  • Snider Financial Group sold 223 Eli Lilly shares in Q2 2026, an estimated $228K.
  • Eli Lilly made up 3.7% of Snider Financial Group's portfolio in Q2 2026, its #6 holding.
  • Snider Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 852 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Snider Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.